C.D.C. (Europe)

In early 2022, ECDC launched a comprehensive strategic foresight initiative to consider and prepare for future public health challenges.

The Jubilee 2025, also known as a Holy Year, will take place in Rome and the Vatican City, Italy, spanning 2025 and concluding on 6 January 2026.

On World Hand Hygiene Day, a new ECDC survey* reveals that 3.1% of the residents in long-term care facilities (LTCFs) had at least one healthcare-associated infection (HAI) at the time of the study.

Today marks an important milestone for ECDC’s cooperation with countries under EU’s Enlargement policy. After 14 years of close collaboration, on 28 April 2025 ECDC formalised its cooperation through the signing of Memoranda of Understanding with Albania, Kosovo*, Montenegro, and with the new EU candidate country, Moldova.

Marking European Immunization Week (EIW) 2025, ECDC highlights the risks of suboptimal vaccination coverage in Europe and publishes a set of operational tools that public health authorities can use to improve vaccination acceptance and uptake.

European Immunization Week (EIW), marked annually during the last week of April, is an initiative led by the World Health Organization (WHO) to raise awareness about the benefits of immunisation as a vital part to prevent diseases and protect life.

Between 23 and 24 April 2025, the European Centre for Disease Prevention and Control (ECDC) carried out a technical visit to Moldova, following a request from the country’s national public health authorities.

Between 7 and 11 April, ECDC visited the WHO Academy together with Africa CDC.

Although progress has been made towards SDG target 3.3 to end the epidemics of HIV, TB, and combatting viral hepatitis B and C and STIs by 2030, the EU/EEA is off track for many of the targets.

Every month ECDC provides detailed epidemiological overview of the worldwide transmission of mpox in its weekly threat report.

The standard call for abstracts for ESCAIDE 2025 is now open and the deadline for submissions is 14 May (23:59 CEST).

New maps published by ECDC show that hotspots for tick-borne encephalitis (TBE) in the EU are mainly concentrated in Central, Eastern, and Northern Europe, based on 2023 notification rates of locally-acquired cases.

On 7–8 April 2025, a technical team from the European Centre for Disease Prevention and Control (ECDC) visited Türkiye to assess the country’s communicable diseases surveillance system.

A three-day training workshop on public health epidemic intelligence and rapid risk assessment (EI/RRA), organised by the European Centre for Disease Prevention and Control (ECDC) under the EU Initiative on Health Security, concluded today in Chișinău, Moldova. The event brought together over 40 public health professionals from Moldova, Armenia, Azerbaijan, and Georgia, with additional facilitators from EU Member States, Eastern European and South Caucasus partner countries and the World Health Organization (WHO).

MediPIET fellows and external participants concluded an intensive training module in Montenegro, focusing on chemical, biological, radiological and nuclear (CBRN) agents and their impact on human health.

ECDC is releasing the results of a survey that provides an overview of HIV testing strategies for blood, tissues, and cells donors within the EU/EEA.

ECDC is releasing the results of a survey that provides an overview of HIV testing strategies for blood, tissues, and cells donors within the EU/EEA.

ECDC has published a set of recommendations for preparedness planning for public health threats, offering tailored guidance for improving readiness for future health emergencies across European Union/European Economic Area (EU/EEA) countries, at both national and regional levels.

On 18 and 19 March 2025, a seminar was held at Africa CDC HQ in Addis Ababa, Ethiopia on Priority Areas for Multisectoral Interventions (PAMIs) for cholera control. The workshop brought together 20 participants from Africa CDC and the Regional Collaboration Centres.

COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).